On Oct. 2, 2020, Humanigen announced that a patient case report on the use of lenzilumabﾙ in critical COVID-19 was published online at OSF Preprints titled ﾓCOVID-19 associated chronic ARDS successfully treated with lenzilumab.ﾔ Sixteen days post-treatment with lenzilumab, the patient was discharged from the hospital on home oxygen.